Bicara Therapeutics Inc. (BCAX) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and thank you for standing by. Welcome to the Bicara Therapeutics First Quarter twenty twenty six Earnings Conference Call. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session. To ask a question during the session, you will need to press 11 on your telephone. You will then hear an automated message advising your hand is raised. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Rachel Frank, Vice President of Investor Relations and Corporate Communications. Please go ahead. Thank you, and good morning, everyone. It's a pleasure to welcome you to Bicara Therapeutics First Quarter twenty twenty six Earnings Call. Earlier this morning, we issued a press release highlighting results from the quarter and recent business progress. You can access the press release as well as the slides that we'll be reviewing today by going to the Investors section of our website. Before we begin, please note that this call will include forward looking statements under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Please refer to our most recent SEC filings for important risk factors that could cause our actual performance and results to materially differ from those expressed or implied in these forward looking statements. Any forward looking statement made on this call represents our views only as of today, and we disclaim any obligation to update any forward looking statements. Joining us on the call today are Claire Mazumdar, Chief Executive Officer Bill Shellman, Chief Medical Officer Ryan Kohlheep, President and Chief Operating Officer and Ivan Hayab, Chief Financial Officer...